Rob talks about another multi-format superstar on today’s Stock Watch.
Abrupt Decay
Rob takes a look a close look at the finance potential of Tezzeret, Agent of Bolas.
Rob takes a good, hard look at this shiny trinket from Coldsnap!
Rob thinks that now’s the time to decide on what to do with it. Time to share your thoughts!
Is it time for you to drain our pockets?
Is there a chance Bloodbraid Elf returns?
Should I give up, or should I just keep making payments?
Adrian breaks down 10 of the best two-drops in Modern, whether they’re worthy buying, and what kind of patterns some of them have seen. Check it out!
Which cards should we target that are rotating? Which cards remaining in Standard will be given new life? Adrian is here with the rundown.
Morgan’s here to cover today’s Commander 2017 deck review: Arcane Wizardry.
On the surface MTG finance looks healthy, but there are some areas of weakness. This begs the question: do we stick with what’s working or shift to the underperformers?
When we get complacent, we ignore the risks associated with investment. David discusses the danger of complacency, and offers a few practical tools to fight it.
After GP San Antonio revealed some new information about Modern, Brian shares his picks for cards to buy in anticipation of future gains.